Phillipos Lisgos

Evaluation of a Four‐drug, Three‐antibiotic, Nonbismuth–containing “Concomitant” Therapy as First‐line <i>Helicobacter pylori</i> Eradication Regimen in Greece

Sotirios D. Georgopoulos, Vasilios Papastergiou, Elias Xirouchakis et al. · Helicobacter · 2012 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +13

Ultrasonographic Prevalence and Factors Predicting Left Ventricular Diastolic Dysfunction in Patients with Liver Cirrhosis: Is There a Correlation between the Grade of Diastolic Dysfunction and the Grade of Liver Disease?

Vasilios Papastergiou, Lamprini Skorda, Phillipos Lisgos et al. · The Scientific World JOURNAL · 2012 · 24 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Hepatitis C virus genotyping in Greece: Unexpected high prevalence of genotype 5a in a Greek island

Stylianos Karatapanis, Panagiota Tsoplou, Vasilios Papastergiou et al. · Journal of Medical Virology · 2011 · 17 citations

Life Sciences, Infectious Diseases, Microbiology +12

Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C

Vasilios Papastergiou, Maria Stampori, Phillipos Lisgos et al. · European Journal of Gastroenterology & Hepatology · 2013 · 13 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17